Hydrocortisone sodium succinate
Hydrocortisone sodium succinate is a generic injectable corticosteroid medication used to treat inflammation, allergies, and certain medical conditions. It is administered by intramuscular or intravenous injection, with each vial containing 100 mg of the active ingredient. Manufactured by Cipla USA Inc. under application ANDA214050. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Hydrocortisone sodium succinate is a generic injectable corticosteroid medication used to treat inflammation, allergies, and certain medical conditions. It is administered by intramuscular or intravenous injection, with each vial containing 100 mg of the active ingredient. Manufactured by Cipla USA Inc. under application ANDA214050. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Hydrocortisone sodium succinate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Hydrocortisone sodium succinate — ANDA 214050 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214050"
}
]
|
| identifier | ANDA214050 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"health-care",
"medications",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Hydrocortisone sodium succinate |
